In the news

The FDA reported that the Ice Cream House recalled all Dairy Ice Cream Products and Non-dairy [Parve] frozen Dessert products due to the potential of Listeria monocytogenes. The recalled products were sold at the Ice Cream House in Brooklyn and through retail supermarkets in New York, New Jersey, and Ohio. This recall is related to the Soft Serve on the go cups, previously recalled by Real Kosher Ice Cream, Inc., where two illnesses have been reported in this outbreak in two states (NY and PA.) Both individuals were hospitalized, but no deaths have been reported to date. The company has ceased producing and distributing the products as the investigation is ongoing. Recalled products include all Ice Cream House branded items currently on the market. The products are packed in clamshells or cake trays with plastic dome covers in various sizes and styles and have an Ice Cream House label. @ https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ice-cream-house-voluntarily-recalling-all-dairy-ice-cream-products-and-non-dairy-parve-frozen#:~:text=to%20Listeria%20Monocytogenes-,The%20Ice%20Cream%20House%20is%20Voluntarily%20Recalling%20All%20Dairy%20Ice,announcement%20as%20a%20public%20service

The FDA issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry produces infant formula under the safest conditions possible. The three companies subject to the letters are ByHeart, Inc., Mead Johnson Nutrition (Reckitt), and Perrigo Wisconsin, LLC. The FDA claims that Actions are part of enhanced oversight and does not advise discarding or avoiding the purchase of any infant formula. The FDA inspected the facilities, issued inspection observations, and initiated recalls (in December 2022, February 2023, and March 2023) to remove products potentially contaminated with Cronobacter sakazakii from the marketplace. The firms must thoroughly conduct root cause investigations and perform subsequent cleaning and sanitation activities. @ https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-three-infant-formula-manufacturers?utm_medium=email&utm_source=govdelivery

China CDC Weekly published a study of foodborne outbreaks due to Bacillus cereus in China 2010-2020. The study describes the characteristics of outbreaks caused by B. cereus in China. From 2010 to 2020, 419 foodborne outbreaks due to B. cereus were reported in China, leading to 7,892 cases, 2,786 hospital admissions, and 5 fatalities. Most outbreaks were recorded in the summer, primarily between May and September. The most recurrent food vehicle was linked with rice or flour-based products. Most outbreaks were in School canteens. Implementing comprehensive guidelines encompassing multiple critical aspects can potentially reduce the occurrence of B. cereus outbreaks. The prevalence of B. cereus outbreaks remained relatively consistent throughout the studied period.  @ https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2023.140

CORE update of August 30, 2023, the CORE list of outbreaks and adverse events includes six active cases. There were two new cases this week. A new outbreak of Salmonella Newport (ref # 1179) not yet linked to a product has been added to the table. FDA has initiated traceback. Another new outbreak is linked to Cryptosporidium (ref #1174), which is not yet linked to any product added to the table. All 11 cases in this outbreak are in Minnesota (MN). FDA is assisting the Minnesota Department of Health and Minnesota Department of Agriculture in this investigation and has initiated traceback. While the investigation is ongoing to determine what product made people sick, the outbreak appears to be over, and there is likely no ongoing risk to consumers. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigations-foodborne-illness-outbreaks?utm_medium=email&utm_source=govdelivery